Haemonetics (HAE) Asset Utilization Ratio (2010 - 2026)

Haemonetics' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.55 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio changed 0.06% year-over-year to 0.55 in Q1 2026; TTM through Mar 2026 was 0.55, a 0.06% change from a year earlier, with the FY2026 full-year figure at 0.55, down 6.02% from the prior year.
• Asset Utilization Ratio grew to 0.55 in Q1 2026 per HAE's latest filing, from 0.53 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.63 in Q3 2023 and bottomed at 0.52 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.55 (2022), against an average of 0.57.
• Biggest YoY gain for Asset Utilization Ratio was 14.98% in 2022; the steepest drop was 18.78% in 2022.
• Year by year, Asset Utilization Ratio stood at 0.6 in 2022, then fell by 0.03% to 0.6 in 2023, then declined by 9.93% to 0.54 in 2024, then dropped by 1.62% to 0.53 in 2025, then advanced by 2.15% to 0.55 in 2026.
• Per Business Quant, the three latest HAE Asset Utilization Ratio figures stand at 0.55 (Q1 2026), 0.53 (Q4 2025), and 0.54 (Q3 2025).